Northern Trust’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$214K Sell
396,153
-2,157
-0.5% -$1.17K ﹤0.01% 3914
2025
Q1
$261K Buy
398,310
+21
+0% +$14 ﹤0.01% 3844
2024
Q4
$406K Buy
398,289
+17,049
+4% +$17.4K ﹤0.01% 3727
2024
Q3
$330K Sell
381,240
-819,807
-68% -$710K ﹤0.01% 3704
2024
Q2
$430K Sell
1,201,047
-27,838
-2% -$9.97K ﹤0.01% 3559
2024
Q1
$824K Sell
1,228,885
-37,931
-3% -$25.4K ﹤0.01% 3397
2023
Q4
$688K Buy
1,266,816
+76,869
+6% +$41.8K ﹤0.01% 3438
2023
Q3
$714K Sell
1,189,947
-12,022
-1% -$7.21K ﹤0.01% 3403
2023
Q2
$1.56M Sell
1,201,969
-46,045
-4% -$59.9K ﹤0.01% 3156
2023
Q1
$2.2M Sell
1,248,014
-39,149
-3% -$68.9K ﹤0.01% 2899
2022
Q4
$4.04M Buy
1,287,163
+72,962
+6% +$229K ﹤0.01% 2610
2022
Q3
$5.95M Buy
1,214,201
+48,370
+4% +$237K ﹤0.01% 2359
2022
Q2
$4.83M Sell
1,165,831
-33,407
-3% -$138K ﹤0.01% 2538
2022
Q1
$6.97M Sell
1,199,238
-37,828
-3% -$220K ﹤0.01% 2370
2021
Q4
$9.28M Sell
1,237,066
-217,931
-15% -$1.63M ﹤0.01% 2283
2021
Q3
$13.1M Sell
1,454,997
-36,445
-2% -$328K ﹤0.01% 2090
2021
Q2
$17.9M Buy
1,491,442
+143,240
+11% +$1.71M ﹤0.01% 1966
2021
Q1
$16.9M Sell
1,348,202
-92,118
-6% -$1.15M ﹤0.01% 1952
2020
Q4
$22.5M Sell
1,440,320
-49,628
-3% -$774K ﹤0.01% 1706
2020
Q3
$14.1M Sell
1,489,948
-84,559
-5% -$799K ﹤0.01% 1883
2020
Q2
$14.1M Buy
1,574,507
+121,465
+8% +$1.09M ﹤0.01% 1883
2020
Q1
$9.26M Sell
1,453,042
-51,565
-3% -$328K ﹤0.01% 1904
2019
Q4
$12.6M Sell
1,504,607
-10,125
-0.7% -$84.7K ﹤0.01% 2031
2019
Q3
$13.7M Buy
1,514,732
+141,263
+10% +$1.28M ﹤0.01% 1949
2019
Q2
$14.8M Buy
1,373,469
+51,137
+4% +$551K ﹤0.01% 1894
2019
Q1
$12.6M Buy
1,322,332
+821
+0.1% +$7.83K ﹤0.01% 1998
2018
Q4
$15.2M Sell
1,321,511
-1,455
-0.1% -$16.7K ﹤0.01% 1796
2018
Q3
$22.4M Buy
1,322,966
+35,166
+3% +$596K 0.01% 1705
2018
Q2
$18.3M Buy
1,287,800
+223,870
+21% +$3.18M ﹤0.01% 1851
2018
Q1
$20.2M Buy
1,063,930
+2,998
+0.3% +$57K 0.01% 1677
2017
Q4
$17.4M Sell
1,060,932
-8,163
-0.8% -$134K ﹤0.01% 1821
2017
Q3
$16M Buy
1,069,095
+121,263
+13% +$1.82M ﹤0.01% 1874
2017
Q2
$8.34M Buy
947,832
+44,656
+5% +$393K ﹤0.01% 2290
2017
Q1
$4.7M Buy
903,176
+10,400
+1% +$54.1K ﹤0.01% 2589
2016
Q4
$2.72M Buy
892,776
+7,906
+0.9% +$24.1K ﹤0.01% 2918
2016
Q3
$4.1M Buy
884,870
+5,414
+0.6% +$25.1K ﹤0.01% 2644
2016
Q2
$5.09M Buy
879,456
+34,772
+4% +$201K ﹤0.01% 2452
2016
Q1
$5.11M Buy
844,684
+18,948
+2% +$115K ﹤0.01% 2398
2015
Q4
$7.54M Buy
825,736
+17,424
+2% +$159K ﹤0.01% 2201
2015
Q3
$4.56M Buy
808,312
+22,379
+3% +$126K ﹤0.01% 2493
2015
Q2
$8.72M Sell
785,933
-7,557
-1% -$83.8K ﹤0.01% 2154
2015
Q1
$12.4M Buy
793,490
+14,633
+2% +$229K ﹤0.01% 1934
2014
Q4
$11.8M Sell
778,857
-31,667
-4% -$482K ﹤0.01% 1942
2014
Q3
$8.74M Sell
810,524
-40,970
-5% -$442K ﹤0.01% 2130
2014
Q2
$13M Sell
851,494
-9,852
-1% -$150K ﹤0.01% 1846
2014
Q1
$15.6M Sell
861,346
-58,931
-6% -$1.07M ﹤0.01% 1780
2013
Q4
$12.8M Buy
920,277
+89,601
+11% +$1.24M ﹤0.01% 1905
2013
Q3
$8.71M Buy
830,676
+10,919
+1% +$115K ﹤0.01% 2114
2013
Q2
$6.4M Buy
+819,757
New +$6.4M ﹤0.01% 2249